Health
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients – EurekAlert
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial, known as ACTIV-3, and as a ”master pro…
IMAGE: Colorized scanning electron micrograph of a cell (purple) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in…
view more
Credit: NIAID
Patients admitted with COVID-19 at select hospitals may now volunteer to enroll in a clinical trial to test the safety and efficacy of a potential new treatment for the disease. The Phase 3 randomized, controlled trial is known as ACTIV-3, and as…
-
General23 hours agoFifth person charged with murder over fatal Bega stabbing denied bail
-
Noosa News18 hours agoDangerous storm pounds south-east Queensland with giant hail, blackouts and widespread damage
-
Noosa News21 hours agoBruce Highway fatal: Grandmother’s heartbreak as daughter and granddaughter killed in Queensland truck crash
-
Noosa News24 hours agoViolent thunderstorms to target southeast QLD and northeast NSW on Monday